Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Invictus Secures $23 Million Financing

Stockhouse Editorial
0 Comments| October 19, 2018


Global cannabis Company Invictus MD Strategies Corp. (TSX: V.GENE, OTCQB: IVTF, Forum) on Friday stated that its bought-deal offering, where the Company issued an aggregate of 11,500,000 Units at a price of $2.00 per Unit for gross proceeds of $23,000,000 (CAD).

For more on this news, click here.

Invictus announced last week that one of its acquisitions, OptionCo, has received its license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR) at its Delta research facility, located in British Columbia.


FULL DISCLOSURE: Invictus MD Strategies Corp. is a paid client of Stockhouse Publishing.




Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Healthcare
Technology
Metals & Mining
Technology
Industrials

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to access this feature.


×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.